Phase 4 IOP Signals Associated With ILUVIEN®
- Registration Number
- NCT02424019
- Lead Sponsor
- Alimera Sciences
- Brief Summary
This study will assess the safety in patients treated with ILUVIEN, with primary focus on IOP.
- Detailed Description
The specific objectives include the study of intraocular pressure (IOP) related data in patients who received ILUVIEN and how it relates to the patient's experiences following prior treatment with a course of corticosteroid which did not result in a clinically significant IOP elevation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 153
- Patients who are eligible for treatment with ILUVIEN based on the Prescribing Information.
- Patients who are unable to understand and sign the Informed Consent Form.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description ILUVIEN 0.19 MG ILUVIEN 0.19 MG All patients will receive ILUVIEN (Fluocinolone Acetonide Intravitreal Insert) 0.19 mg.
- Primary Outcome Measures
Name Time Method Intraocular Pressure 36 months Intraocular pressure of the ILUVIEN treated eye
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (41)
University of Maryland Eye Associates
🇺🇸Baltimore, Maryland, United States
The University of Illinois at Chicago
🇺🇸Chicago, Illinois, United States
Sabates Eye Center Research Division
🇺🇸Leawood, Kansas, United States
Virginia Retina Center
🇺🇸Warrenton, Virginia, United States
Medical Center Ophthalmology Associates
🇺🇸San Antonio, Texas, United States
Hampton Roads Retina Center
🇺🇸Chesapeake, Virginia, United States
Retina Centers, P.C.
🇺🇸Tucson, Arizona, United States
Retina Vitreous Associates of Florida
🇺🇸Saint Petersburg, Florida, United States
Wayne State University
🇺🇸Detroit, Michigan, United States
Eye Care Center of Northern Colorado
🇺🇸Longmont, Colorado, United States
Southeast Retina Center, P.C.
🇺🇸Augusta, Georgia, United States
Johns Hopkins Hospital
🇺🇸Baltimore, Maryland, United States
Illinois Retina Associates, SC
🇺🇸Oak Park, Illinois, United States
Eye Associates of Northeast Louisiana
🇺🇸West Monroe, Louisiana, United States
Eyesight Ophthalmic Services, PA
🇺🇸Portsmouth, New Hampshire, United States
Retina Research Center
🇺🇸Austin, Texas, United States
New Jersey Retina
🇺🇸New Brunswick, New Jersey, United States
Retina Associates of New Jersey
🇺🇸Teaneck, New Jersey, United States
Pennsylvania Retina Specialist, PC
🇺🇸Camp Hill, Pennsylvania, United States
Joseph R. Podhorzer, MD PLLC
🇺🇸Brooklyn, New York, United States
Macula Care
🇺🇸New York, New York, United States
Tulsa Retina Consultants
🇺🇸Tulsa, Oklahoma, United States
Retina Consultants of Arizona
🇺🇸Phoenix, Arizona, United States
Retina and Macula Institute
🇺🇸Glendale, California, United States
Atlantis Eye Care
🇺🇸Huntington Beach, California, United States
Orange County Retina Medical Group
🇺🇸Santa Ana, California, United States
Retina Consultants of Hawaii
🇺🇸'Aiea, Hawaii, United States
Chicagoland Eye and Retina Foundation
🇺🇸Chicago, Illinois, United States
University Retina and Macula Associates
🇺🇸Oak Forest, Illinois, United States
Wolfe Eye Clinic
🇺🇸West Des Moines, Iowa, United States
Carle Foundation Hospital
🇺🇸Urbana, Illinois, United States
Paducah Retinal Center
🇺🇸Paducah, Kentucky, United States
Discover Vision Centers
🇺🇸Independence, Missouri, United States
Lifelong Vision Foundation
🇺🇸Chesterfield, Missouri, United States
Ophthalmic Consultants of Long Island
🇺🇸Lynbrook, New York, United States
Laurel Eye Clinic
🇺🇸Brookville, Pennsylvania, United States
Island Retina
🇺🇸Shirley, New York, United States
Southeastern Retina Associates, PC
🇺🇸Kingsport, Tennessee, United States
Cascade Eye and Skin
🇺🇸University Place, Washington, United States
Northern California Retina Vitreous Medical Group, Inc.
🇺🇸Mountain View, California, United States
Valley Retina Institute, PA
🇺🇸McAllen, Texas, United States